In wild-type TP53 cell lines, the growth delay is explained by a partial blockade of myeloma cells in the G2/M phase of the cell cycle, in association with p53 phosphorylation and stabilization, p21Cip1 expression, and no change in p27KIP1. The gene discussed is CDKN1A; the disease is plasma cell myeloma.